Article Text

Download PDFPDF
Treating multivessel disease in the era of coated stents: conclusion
  1. C Di Mario,
  2. H Griffiths
  1. Correspondence to:
    Professor Carlo di Mario
    Royal Brompton & Harefield NHS Trust, Sydney Street, London SW3 6NP, UK;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The worse long term outcome observed after percutaneous transluminal coronary angioplasty (PTCA) than after coronary artery bypass grafting (CABG) in patients at high risk of restenosis and disease progression such as diabetics,1–4 remind us that there is a substantial difference between treating a focal lesion with percutaneous coronary intervention and the use of arterial or vein grafts which bypass all proximal and mid segments of native coronary arteries. Interventionalists may argue that repair of the native arteries avoids the problem of accelerated disease of the bypass conduits and the occlusion of native arteries often seen years after implantation of vein grafts, situations difficult to handle both with surgery and angioplasty. Still, at least in the first few years after CABG and possibly much longer for arterial grafts, a …

View Full Text